| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |